Hong Cheng

15PUBLICATIONS
16CO-AUTHORS
Cardiology (incl. cardiovascular diseases)Major global burdens of diseaseNutrigenomics and personalised nutritionPredictive and prognostic markersPeripheral nervous system
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Mar 23, 2026
Role of Sodium-Glucose Transport Protein-2 Inhibitors in Renal Protection: A Narrative Review from the Cardiovascular-Kidney-Metabolic Interconnection.

Nan Ye, Hong Cheng

|Jan 12, 2026
Meta-Analysis of Randomized Controlled Trials Assessing the Efficacy and Safety of Endothelin Receptor Antagonists in CKD.

Yunqi Shi, Nan Ye, Guoqin Wang

|Aug 11, 2025
A rare case of sero-negative anti-glomerular basement membrane disease combined with diabetic nephropathy and literature review.

Wenbo Wang, Weiyi Guo, Xiaoyi Xu

|Apr 28, 2025
Factors influencing early renal function changes after SGLT2 inhibitors use and its long-term prognosis: a real-world retrospective study.

Bing Xie, Nan Ye, Guoqin Wang

|Feb 21, 2025
Analysis of Cardiovascular and Cerebrovascular Prognosis and Risk Factors in Patients with Primary Membranous Nephropathy.

Nan Ye, Lei Yang, Guoqin Wang

|Oct 27, 2024
The Selective Endothelin Receptor Antagonist SC0062 in IgA Nephropathy: A Randomized Double-Blind Placebo-Controlled Clinical Trial.

Hiddo J L Heerspink, Xiaoying Du, Yan Xu

Pageof 3

Frequent Collaborators

3 joint publications

Hong-Liang Rui

3 joint publications

Nan Ye

2 joint publications

Guoqin Wang

1 joint publications

Yi-Pu Chen